Sorafenib Tablet, Film Coated
Product Images NDC 13668-682

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sorafenib (NDC 13668-682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Bottle Label 1)

This is a description for Sorafenib tablets. Each film-coated tablet contains 200mg of Sorafenib, with 30 tablets per package. The tablets should be stored in a dry place, at 20°C to 25°C (68°F to 77°F), with a permitted range of 15°C to 30°C (59°F and 86°F). They should be dispensed in a tight container with a child-resistant closure and kept out of reach of children. The manufacturer is Torrent Pharmaceuticals LTD., located in Bileshwarpura-382729, India, and sold by Torrent Pharma INC., in Basking Ridge, NJ 07920.*

FDA Label Image

Figure 01 (Figure 01)

The text describes a clinical trial regarding Sorafenib, a medication used to treat kidney and liver cancer. The trial had 299 patients using Sorafenib tablets and 303 patients using a placebo. The median survival time of patients using Sorafenib was 10.7 months compared to 7.9 months for patients using the placebo. The Hazard Ratio (HR) was 0.69 with a P-value of 0.00058, indicating statistical significance. The text also includes a chart showing the number of patients at risk over time for Sorafenib tablets and Placebo.*

FDA Label Image

Figure 02 (Figure 02)

The text appears to be a survival analysis data table comparing Sorafenib tablets to Placebo treatment. The median number of days of survival for patients treated with Sorafenib is shown to be 167 days, whereas the same value for patients treated with Placebo is 84 days. The table also includes a graph depicting the progression of survival over the course of treatment.*

FDA Label Image

Figure 03 (Figure 03)

FDA Label Image

Torrent Logo 1 (Logo 01)

FDA Label Image

Torrent Logo 2 (Logo 02)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.